A214610 Stock Overview
MiCo BioMed Co., Ltd. provides on-site diagnostic systems based on Lab-on-a-Chip technology.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
MiCo BioMed Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,476.00 |
| 52 Week High | ₩6,908.46 |
| 52 Week Low | ₩1,444.00 |
| Beta | 0.43 |
| 1 Month Change | -14.83% |
| 3 Month Change | -16.37% |
| 1 Year Change | -75.77% |
| 3 Year Change | -87.17% |
| 5 Year Change | -73.95% |
| Change since IPO | -83.05% |
Recent News & Updates
Shareholder Returns
| A214610 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -1.6% | 3.0% | -3.3% |
| 1Y | -75.8% | 26.1% | 1.2% |
Return vs Industry: A214610 underperformed the KR Medical Equipment industry which returned 26.1% over the past year.
Return vs Market: A214610 underperformed the KR Market which returned 1.2% over the past year.
Price Volatility
| A214610 volatility | |
|---|---|
| A214610 Average Weekly Movement | 5.8% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.9% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A214610's share price has been volatile over the past 3 months.
Volatility Over Time: A214610's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 88 | Young S Hong | www.micobiomed.com |
MiCo BioMed Co., Ltd. provides on-site diagnostic systems based on Lab-on-a-Chip technology. The company offers molecular diagnostics devices comprising Veri-Q PREP M16 (G2-16TU) System, a device which include, membrane to extract nucleic acid using tube; VERI-Q PCR 316, a device to get the result in a short time using plastic chip; VERI-Q PCR 204 (G2-4), a device to deliver the real-time PCR system; PCR and sample prep kits; and LabChip, sample tube, and pre-filtering column. It also provides biological chemistry products, including VERI-Q Multi, a cholesterol diagnostic product; VERI-Q RED, a hemoglobin monitoring system; Healthy- Q Life, a cholesterol monitoring system; Healthy- Q Multi, a multifunctional monitoring system; and Healthy- Q Balance Pro.
MiCo BioMed Co., Ltd. Fundamentals Summary
| A214610 fundamental statistics | |
|---|---|
| Market cap | ₩64.29b |
| Earnings (TTM) | -₩25.77b |
| Revenue (TTM) | ₩5.37b |
12.0x
P/S Ratio-2.5x
P/E RatioIs A214610 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A214610 income statement (TTM) | |
|---|---|
| Revenue | ₩5.37b |
| Cost of Revenue | ₩12.34b |
| Gross Profit | -₩6.97b |
| Other Expenses | ₩18.80b |
| Earnings | -₩25.77b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -591.70 |
| Gross Margin | -129.88% |
| Net Profit Margin | -480.20% |
| Debt/Equity Ratio | 28.7% |
How did A214610 perform over the long term?
See historical performance and comparison